![](/img/cover-not-exists.png)
A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard- fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to fu et al. IJROBP 2000;48:7–16: actuarial estimates of late normal-tissue effects . . . now!
Hans-Hermann Dubben, Hans-Peter Beck-BornholdtVolume:
51
Year:
2001
Language:
english
DOI:
10.1016/s0360-3016(01)01661-3
File:
PDF, 25 KB
english, 2001